The ticker symbol BDSX represents Biodesix, Inc., a data-driven diagnostic solutions company utilized by healthcare professionals and oncologists to improve patient outcomes. Its proprietary blood-based tests and genomic assays are used primarily for the early detection, risk assessment, and therapeutic monitoring of lung cancer and other complex diseases. By providing rapid and actionable molecular insights, these diagnostic tools help physicians select personalized treatment paths and monitor therapy responses effectively.